Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Beule, Dieter Dr. (2) Birchmeier, Walter Prof. Dr. (1) Cakmak-Görür, Nese Dr. (1) Dahlmann, Mathias Dr. (5) Daniel, Peter Prof. Dr. (1) Dhamodaran, Arunraj (1) Kammertöns, Thomas Dr. (3) Kieback, Elisa Dr. (1) Kobelt, Dennis Dr. (7) Koch, Gudrun (1) Kopp, Joachim Dr. (1) Leisegang, Matthias Prof. Dr. rer. nat. (2) Leutz, Achim Prof. Dr. (1) Lorenz, Felix Dr. (1) Malchin, Victoria (1) Marko, Lajos Dr. (1) Pezzutto, Antonio Prof. Dr. (2) Poncette, Lucia (1) Rhein, Simone Dr. (1) Röefzaad, Claudia (1) Schlag, Peter M. Prof. Dr. (37) Schmitt, Clemens Prof. Dr. (2) Siffrin, Volker (1) Smith, Janice (2) Stein, Ulrike Prof. Dr. (24) Uckert, Wolfgang Prof. Dr. (4) Walther, Wolfgang Prof. Dr. (7) Willimsky, Gerald Dr. (4) Zimmermann, Karin Dr. (1) (-) Blankenstein, Thomas Prof. Dr. (17) Bioinformatics and Omics Data Science (1) Biologie maligner Lymphome (13) Genetik und Genomik von Herz- Kreislauferkrankungen (1) Immunregulation und Krebs (1) Mikroumgebung als Regulator bei Autoimmunität und Krebs (1) (-) Molekulare Immunologie und Gentherapie (17) Proteom Dynamik (2) RNA Biologie und Posttranscriptionale Regulation (1) Strukturbiologie Membran-assoziierter Prozesse (1) Systembiologie von Gen-regulatorischen Elementen (4) Translational Bioinformatics (2) (-) Translationale Onkologie solider Tumore (1) Zellzustände und ihre Funktionsweisen (1) 1992 (4) 1993 (7) 1994 (5) 1995 (8) 1996 (6) 1997 (9) 1998 (9) 1999 (2) 2000 (8) 2001 (5) 2002 (5) 2003 (10) 2004 (8) 2005 (10) 2006 (1) 2007 (5) (-) 2008 (5) 2009 (2) 2010 (7) 2011 (5) 2012 (6) 2013 (11) (-) 2014 (3) (-) 2015 (3) 2016 (4) 2017 (6) 2018 (4) (-) 2019 (6) 2021 (4) 2022 (6) 2023 (4) 2024 (2) 17 Ergebnisse: Active Filter: Blankenstein, Thomas Prof. Dr.Molekulare Immunologie und Gentherapie Translationale Onkologie solider Tumore2008201420152019 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 15. Juli 2014 / Int J Cancer Permissive expansion and homing of adoptively transferred T cells in tumor-bearing hosts C. Perez A. Jukica J.J. Listopad K. Anders A.A. Kühl C. Loddenkemper T. Blankenstein J. Charo 01. April 2015 / Curr Opin Immunol Targeting cancer-specific mutations by T cell receptor gene therapy T. Blankenstein M. Leisegang W. Uckert H. Schreiber 01. April 2015 / Nat Biotechnol Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice M. Obenaus C. Leitão M. Leisegang X. Chen I. Gavvovidis P. van der Bruggen W. Uckert D.J. Schendel T. Blankenstein 15. April 2015 / Int J Cancer Gene expression profiling of peripheral blood mononuclear cells during treatment with a gene-modified allogeneic tumor cell vaccine in advanced renal cell cancer: tumor-induced immunosuppression and a possible role for NF-κB A. Flörcken M. Grau A. Wolf A. Weilemann J. Kopp B. Dörken T. Blankenstein A. Pezzutto P. Lenz G. Lenz J. Westermann 01. Dezember 2014 / Canc Res Efficacy of CAR T-cell therapy in large tumors relies upon stromal targeting by IFNγ A. Textor J.J. Listopad L.L. Wührmann C. Perez A. Kruschinski M. Chmielewski H. Abken T. Blankenstein J. Charo 02. Januar 2019 / J Clin Invest Effective NY-ESO-1-specific MHC II-restricted T cell receptors from antigen-negative hosts enhance tumor regression L. Poncette X. Chen F.K.M. Lorenz T. Blankenstein 01. April 2019 / Leukemia Intracellular expression of FLT3 in Purkinje cells: implications for adoptive T-cell therapies N. Çakmak-Görür J. Radke S. Rhein E. Schumann G. Willimsky F.L. Heppner T. Blankenstein A. Pezzutto 02. September 2019 / BMC Bioinformatics SigsPack, a package for cancer mutational signatures F. Schumann E. Blanc C. Messerschmidt T. Blankenstein A. Busse D. Beule 07. Februar 2019 / Front Immunol Interferon-γ receptor signaling in dendritic cells restrains spontaneous proliferation of CD4(+) T cells in chronic lymphopenic mice L. Knop C. Frommer D. Stoycheva K. Deiser U. Kalinke T. Blankenstein T. Kammertoens I.R. Dunay T. Schüler 24. März 2019 / OncoImmunology Localization-associated immune phenotypes of clonally expanded tumor-infiltrating T cells and distribution of their target antigens in rectal cancer L. Penter K. Dietze J. Ritter M.F. Lammoglia Cobo J. Garmshausen F. Aigner L. Bullinger H. Hackstein S. Wienzek-Lischka T. Blankenstein M. Hummel K. Dornmair L. Hansmann Seitennummerierung Aktuelle Seite 1 Seite 2 Nächste Seite Next › Letzte Seite Last »
15. Juli 2014 / Int J Cancer Permissive expansion and homing of adoptively transferred T cells in tumor-bearing hosts C. Perez A. Jukica J.J. Listopad K. Anders A.A. Kühl C. Loddenkemper T. Blankenstein J. Charo
01. April 2015 / Curr Opin Immunol Targeting cancer-specific mutations by T cell receptor gene therapy T. Blankenstein M. Leisegang W. Uckert H. Schreiber
01. April 2015 / Nat Biotechnol Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice M. Obenaus C. Leitão M. Leisegang X. Chen I. Gavvovidis P. van der Bruggen W. Uckert D.J. Schendel T. Blankenstein
15. April 2015 / Int J Cancer Gene expression profiling of peripheral blood mononuclear cells during treatment with a gene-modified allogeneic tumor cell vaccine in advanced renal cell cancer: tumor-induced immunosuppression and a possible role for NF-κB A. Flörcken M. Grau A. Wolf A. Weilemann J. Kopp B. Dörken T. Blankenstein A. Pezzutto P. Lenz G. Lenz J. Westermann
01. Dezember 2014 / Canc Res Efficacy of CAR T-cell therapy in large tumors relies upon stromal targeting by IFNγ A. Textor J.J. Listopad L.L. Wührmann C. Perez A. Kruschinski M. Chmielewski H. Abken T. Blankenstein J. Charo
02. Januar 2019 / J Clin Invest Effective NY-ESO-1-specific MHC II-restricted T cell receptors from antigen-negative hosts enhance tumor regression L. Poncette X. Chen F.K.M. Lorenz T. Blankenstein
01. April 2019 / Leukemia Intracellular expression of FLT3 in Purkinje cells: implications for adoptive T-cell therapies N. Çakmak-Görür J. Radke S. Rhein E. Schumann G. Willimsky F.L. Heppner T. Blankenstein A. Pezzutto
02. September 2019 / BMC Bioinformatics SigsPack, a package for cancer mutational signatures F. Schumann E. Blanc C. Messerschmidt T. Blankenstein A. Busse D. Beule
07. Februar 2019 / Front Immunol Interferon-γ receptor signaling in dendritic cells restrains spontaneous proliferation of CD4(+) T cells in chronic lymphopenic mice L. Knop C. Frommer D. Stoycheva K. Deiser U. Kalinke T. Blankenstein T. Kammertoens I.R. Dunay T. Schüler
24. März 2019 / OncoImmunology Localization-associated immune phenotypes of clonally expanded tumor-infiltrating T cells and distribution of their target antigens in rectal cancer L. Penter K. Dietze J. Ritter M.F. Lammoglia Cobo J. Garmshausen F. Aigner L. Bullinger H. Hackstein S. Wienzek-Lischka T. Blankenstein M. Hummel K. Dornmair L. Hansmann